299 related articles for article (PubMed ID: 24590509)
21. The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity.
Harding EK; Dedek A; Bonin RP; Salter MW; Snutch TP; Hildebrand ME
Br J Pharmacol; 2021 Sep; 178(17):3517-3532. PubMed ID: 33871884
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
23. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat.
De Caro C; Russo R; Avagliano C; Cristiano C; Calignano A; Aramini A; Bianchini G; Allegretti M; Brandolini L
Br J Pharmacol; 2018 May; 175(10):1691-1706. PubMed ID: 29485712
[TBL] [Abstract][Full Text] [Related]
25. Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
Orestes P; Bojadzic D; Lee J; Leach E; Salajegheh R; Digruccio MR; Nelson MT; Todorovic SM
J Physiol; 2011 Jan; 589(Pt 1):135-48. PubMed ID: 21059758
[TBL] [Abstract][Full Text] [Related]
26. Involvement of hyperpolarization-activated, cyclic nucleotide-gated cation channels in dorsal root ganglion in neuropathic pain.
Wan Y
Sheng Li Xue Bao; 2008 Oct; 60(5):579-80. PubMed ID: 18958363
[TBL] [Abstract][Full Text] [Related]
27. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Marger F; Gelot A; Alloui A; Matricon J; Ferrer JF; Barrère C; Pizzoccaro A; Muller E; Nargeot J; Snutch TP; Eschalier A; Bourinet E; Ardid D
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11268-73. PubMed ID: 21690417
[TBL] [Abstract][Full Text] [Related]
28. Voltage-gated sodium channels: therapeutic targets for pain.
Dib-Hajj SD; Black JA; Waxman SG
Pain Med; 2009 Oct; 10(7):1260-9. PubMed ID: 19818036
[TBL] [Abstract][Full Text] [Related]
29. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels.
Shan Z; Cai S; Yu J; Zhang Z; Vallecillo TGM; Serafini MJ; Thomas AM; Pham NYN; Bellampalli SS; Moutal A; Zhou Y; Xu GB; Xu YM; Luo S; Patek M; Streicher JM; Gunatilaka AAL; Khanna R
ACS Chem Neurosci; 2019 Jun; 10(6):2939-2955. PubMed ID: 30946560
[TBL] [Abstract][Full Text] [Related]
30. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q
J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317
[TBL] [Abstract][Full Text] [Related]
31. Opening paths to novel analgesics: the role of potassium channels in chronic pain.
Tsantoulas C; McMahon SB
Trends Neurosci; 2014 Mar; 37(3):146-58. PubMed ID: 24461875
[TBL] [Abstract][Full Text] [Related]
32. Na
Israel MR; Tanaka BS; Castro J; Thongyoo P; Robinson SD; Zhao P; Deuis JR; Craik DJ; Durek T; Brierley SM; Waxman SG; Dib-Hajj SD; Vetter I
J Physiol; 2019 Jul; 597(14):3751-3768. PubMed ID: 31087362
[TBL] [Abstract][Full Text] [Related]
33. Targeting N-type and T-type calcium channels for the treatment of pain.
McGivern JG
Drug Discov Today; 2006 Mar; 11(5-6):245-53. PubMed ID: 16580601
[TBL] [Abstract][Full Text] [Related]
34. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
35. Kainate receptor signaling in pain pathways.
Bhangoo SK; Swanson GT
Mol Pharmacol; 2013 Feb; 83(2):307-15. PubMed ID: 23095167
[TBL] [Abstract][Full Text] [Related]
36. Towards the discovery of novel T-type calcium channel blockers.
Lory P; Chemin J
Expert Opin Ther Targets; 2007 May; 11(5):717-22. PubMed ID: 17465728
[TBL] [Abstract][Full Text] [Related]
37. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S
PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104
[TBL] [Abstract][Full Text] [Related]
38. Calcium channel modulation as a target in chronic pain control.
Patel R; Montagut-Bordas C; Dickenson AH
Br J Pharmacol; 2018 Jun; 175(12):2173-2184. PubMed ID: 28320042
[TBL] [Abstract][Full Text] [Related]
39. Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels.
Zhang Y; Qin W; Qian Z; Liu X; Wang H; Gong S; Sun YG; Snutch TP; Jiang X; Tao J
Sci Signal; 2014 Oct; 7(346):ra94. PubMed ID: 25292213
[TBL] [Abstract][Full Text] [Related]
40. Targeting cell surface trafficking of pain-facilitating receptors to treat chronic pain conditions.
Ma W; Quirion R
Expert Opin Ther Targets; 2014 Apr; 18(4):459-72. PubMed ID: 24512266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
